ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bury, T
Right arrow Articles by Radermecker, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bury, T
Right arrow Articles by Radermecker, M
Eur Respir J 1996; 9: 2560-2564
Copyright © ERS Journals Ltd 1996

Original Articles

Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer

T Bury, P Paulus, A Dowlati, JL Corhay, T Weber, B Ghaye, J Schoffers, R Limet, A Albert, P Rigo, and M Radermecker

Recent studies have shown limitations of morphological imaging in staging mediastinal lymph node involvement in lung cancer. In contrast to computed tomography (CT), which depends primarily on anatomical imaging features, positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) depends mainly on the metabolic characteristics of a tissue for the diagnosis of disease. We have performed a prospective study comparing FDG-PET and CT of the thorax in the presurgical assessment of the mediastinum in 50 patients with newly diagnosed non-small cell lung cancer (NSCLC). CT and PET scans were interpreted separately, and results were compared to pathological staging obtained during thoracotomy. Hilar or mediastinal lymph node involvement was present in 58%. In staging for lymph node involvement, CT had a sensitivity of 72% and specificity of 81%, whereas PET had a sensitivity and specificity of 90% and 86%, respectively. When the PET study was compared to histological results, there were four cases showing more advanced mediastinal involvement with PET and four cases showing less involvement with PET. From our preliminary results, we conclude that positron emission tomography with 18-fluorodeoxyglucose is significantly more accurate than computed tomography in the mediastinal staging of non-small cell lung cancer.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. S. Groth, B. A. Whitson, J. D'Cunha, M. A. Maddaus, M. Alsharif, and R. S. Andrade
Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes: A Single Institution's Early Learning Curve
Ann. Thorac. Surg., October 1, 2008; 86(4): 1104 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Melek, M. Z. Gunluoglu, A. Demir, H. Akin, A. Olcmen, and S. I. Dincer
Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer
Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 294 - 299.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
A. Ebihara, H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Uno, I. Kuwahira, and K. Eguchi
Characteristics of Advantages of Positron Emission Tomography over Computed Tomography for N-staging in Lung Cancer Patients
Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 694 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. K. LeBlanc, B. M. Devereaux, T. F. Imperiale, K. Kesler, J. M. DeWitt, O. Cummings, D. Ciaccia, S. Sherman, P. Mathur, D. Conces, et al.
Endoscopic Ultrasound in Non-Small Cell Lung Cancer and Negative Mediastinum on Computed Tomography
Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 177 - 182.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. Duysinx, D. Nguyen, R. Louis, D. Cataldo, T. Belhocine, P. Bartsch, and T. Bury
Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging
Chest, February 1, 2004; 125(2): 489 - 493.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]

Home page
 JNMHome page
J. D. Bradley, C. A. Perez, F. Dehdashti, and B. A. Siegel
Implementing Biologic Target Volumes in Radiation Treatment Planning for Non-Small Cell Lung Cancer
J. Nucl. Med., January 1, 2004; 45(90010): 96S - 101.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens
Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis
Ann Intern Med, December 2, 2003; 139(11): 879 - 892.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. K. LeBlanc, R. Espada, and G. Ergun
Non-small Cell Lung Cancer Staging Techniques and Endoscopic Ultrasound: Tissue Is Still the Issue
Chest, May 1, 2003; 123(5): 1718 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Fritscher-Ravens, K. H. Bohuslavizki, L. Brandt, C. Bobrowski, C. Lund, W. T. Knofel, and A. Pforte
Mediastinal Lymph Node Involvement in Potentially Resectable Lung Cancer: Comparison of CT, Positron Emission Tomography, and Endoscopic Ultrasonography With and Without Fine-Needle Aspiration
Chest, February 1, 2003; 123(2): 442 - 451.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C.-M. Kirsch, and H.-J. Schafers
Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy
Ann. Thorac. Surg., January 1, 2003; 75(1): 231 - 236.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. M. Toloza, L. Harpole, and D. C. McCrory
Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
Chest, January 1, 2003; 123 (2009): 137S - 146S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H.-P. Hauber, K. H. Bohuslavizki, C. H. Lund, A. Fritscher-Ravens, A. Meyer, and A. Pforte
Positron Emission Tomography in the Staging of Small-Cell Lung Cancer : A Preliminary Study
Chest, March 1, 2001; 119(3): 950 - 954.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. P. Dunagan, R. Chin Jr., T. W. McCain, L. D. Case, B. A. Harkness, T. Oaks, and E. F. Haponik
Staging by Positron Emission Tomography Predicts Survival in Patients With Non-small Cell Lung Cancer
Chest, February 1, 2001; 119(2): 333 - 339.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. W. McCain, D. P. Dunagan, R. Chin Jr., T. Oaks, B. A. Harkness, and E. F. Haponik
The Usefulness of Positron Emission Tomography in Evaluating Patients for Pulmonary Malignancies
Chest, December 1, 2000; 118(6): 1610 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
B. A. Dwamena, S. S. Sonnad, J. O. Angobaldo, and R. L. Wahl
Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s-Meta-analytic Comparison Of PET and CT
Radiology, November 1, 1999; 213(2): 530 - 536.
[Abstract] [Full Text]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. U Berlangieri, A. M Scott, S. R Knight, G. J Fitt, O. F Hennessy, H. J Tochon-Danguy, C Peter Clarke, and W John McKay
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S25 - S30.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. J. Scott, J. Shepherd, and S. S. Gambhir
Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis
Ann. Thorac. Surg., December 1, 1998; 66(6): 1876 - 1883.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.